Login To Trade  |  About IIFL
  • NIFTY  8543.05  10.2 0.12%
  • SENSEX 28187.06  72.5 0.26%

Covidien to buy Somanetics

India Infoline News Service | Mumbai | June 16, 2010 17:06 IST

The deal values Somanetics at a premium of US$6.10, or 32%, over its closing price of US$18.9 a share on 15th June.

Covidien Plc plans to buy Somanetics Corp. for US$25 a share in cash, according to reports. The deal valued at US$250mn. Covidien said the acquisition would broaden its medical equipment product offerings and create earnings growth over time. The deal values Somanetics at a premium of US$6.10, or 32%, over its closing price of US$18.9 a share on 15th June.






Turn your smartphone into a powerful mobile trading platform - Know more!!!

Read more on: Covidien  to  buy  Somanetics   
article
113101301220
Covidien to buy Somanetics
Covidien to buy Somanetics
The deal values Somanetics at a premium of US$6.10, or 32%, over its closing price of US$18.9 a share on 15th June.
http://www.indiainfoline.com/article/news-sector-pharma-healthcare/covidien-to-buy-somanetics-113101301220_1.html
June 16, 2010 17:06 IST
http://content.indiainfoline.com/_media/iifl/img/article/default/glo_news.jpg
Covidien to buy Somanetics
Pharma & Healthcare
$rawVideoFileUrl$
$videoPlayerUrl$
Recent Reports

Revival some time away

India Infoline Research Team / 10:30, Jul 13, 2015

Tourism Finance Corp (TFCIL), a niche financier of tourism related projects and activities, has witnessed a sharp moderation in loan growth from 32% in FY12 to just 1% in FY14

News